S72 Omics in PCOS

Program: Symposia
Translational Session
Monday, April 4, 2016: 11:45 AM-1:15 PM
Room 205 (BCEC)
Chair:
Helena Jane Teede, MBBS, PhD, FRACP, Monash University, Melbourne, Australia

Nothing to Disclose: HJT Disclosure Not Provided: HFE
11:45 AM
Jan M McAllister, PhD, Pathology, Pennsylvania State University, Hershey, PA
Nothing to Disclose: JMM
12:15 PM
Manuela Simoni, MD, PhD, Dip. di Scienze Biomediche, Metaboliche e Neuroscienze, Università di Modena e Reggio Emilia, Modena, Italy
Nothing to Disclose: MS
12:45 PM
Andrea Dunaif, MD, Northwestern University Feinberg School of Medicine, Chicago, IL
Nothing to Disclose: AD
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire